Enhance your practice with CMEand tools that focus on the managementand treatment of patients with cancer.
Moving Toward Biomarker-Driven Care in Bladder Cancer
Benjamin Garmezy, MD
Optimizing Patient Selection for Perioperative Therapy in Bladder Cancer
What's Next for Urothelial Cancer Treatment?
Supportive Care Before CLL Treatment: Infection Risk and Comorbidity Management
Kerry A. Rogers, MD
Adapting CV Risk Reduction Strategies for Cancer Survivorship
Stephanie Dixon, MD, MPH
Making the Most of WCLC 2026: A Guide for Early-Career Professionals
Triparna Sen, PhD
Closing Gaps in CRC Screening: From Stool-Based Testing to Timely Colonoscopy
Shelina Ramnarine, PhD
David A. Johnson, MD, FACG, FACP
Closing the Colonoscopy Follow-Up Gap: Insights from a JNCCN Study
Peter Buch, MD, FACG, AGAF, FACP
Mallik Greene, PhD
Jordan Karlitz, MD
Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders
Komal Jhaveri, MD, FACP
Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
Virginia Kaklamani, MD, DSc
Translating Safety Data Into Practice: Effective AE Management in Oral SERD and PROTAC Regimens
Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Ineligible Patients
Saad Z. Usmani, MD, MBA
Natalie S. Callander, MD
Myeloid Mutations in ALL: Disease Risk and Prognostic Implications
Caner Saygin, MD
How Myeloid Mutations in ALL Inform Treatment Decisions
Supportive Care During and After CLL Treatment: What to Prioritize
A Look at WCLC 2026: Pivotal Trials and Emerging Directions
Reducing Cardiovascular Risk in Adult Survivors of Childhood Cancer
A Long-Term View of Cardiovascular Risk After Cancer Treatment
The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
Closing the Evidence Gap in Metastasis-Directed Therapy for mBC
Lajos Pusztai, MD, DPhil
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.